Related Experiment Video
Updated: May 20, 2026

Isolation and Culture of Primary Oral Keratinocytes from the Adult Mouse Palate
Published on: September 24, 2021
MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis
Sheetal Bhan1, Alice Chuang, Sandeep S Negi
1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
Abstract:
Cancer testis antigens (CTAs) are proteins that are normally expressed only in male germ cells and are aberrantly upregulated in a variety of cancers such as melanomas and lung cancer. MAGEA proteins belong to Class I CTAs and are being utilized as targets for cancer immunotherapy. Despite the discovery of the first CTA (MAGEA1) 20 years ago, the functions of these proteins remain poorly understood and evidence suggests both oncogenic as well as tumor suppressive roles for these proteins. Herein, we investigated the role of MAGEA4 in promoting cell growth. When overexpressed, MAGEA4 promotes growth of spontaneously transformed normal oral keratinocytes (NOK-SI). To understand the mechanism of growth stimulation by MAGEA4, we explored the effect of overexpressing MAGEA4 on cell cycle and apoptosis. MAGEA4 inhibits growth arrest of cells in the G1 phase of the cell cycle. We also found that overexpression of MAGEA4 inhibits G418-induced apoptosis of NOK-SI cells. Interestingly, this inhibition was accompanied by repression of two p53 downstream genes, BAX and CDKN1A. Our results indicate that MAGEA4 promotes growth by preventing cell cycle arrest and by inhibiting apoptosis mediated by the p53 transcriptional targets.
Insights
Cancer testis antigens (CTAs), like MAGEA4, promote cancer growth by preventing cell cycle arrest and inhibiting apoptosis. This study reveals MAGEA4
Area of Science:
- Oncology
- Molecular Biology
- Cancer Immunotherapy
Background:
- Cancer testis antigens (CTAs) are aberrantly expressed in various cancers.
- MAGEA proteins, a subset of CTAs, are investigated for their roles in cancer.
- The precise functions of CTAs, including MAGEA4, remain largely undefined.
Purpose of the Study:
- To investigate the role of MAGEA4 in promoting cancer cell growth.
- To elucidate the molecular mechanisms by which MAGEA4 influences cell cycle and apoptosis.
Main Methods:
- Overexpression of MAGEA4 in normal oral keratinocytes (NOK-SI).
- Analysis of cell cycle progression.
- Assessment of apoptosis induction (G418-induced).
- Quantification of p53 downstream gene expression (BAX, CDKN1A).
Main Results:
- MAGEA4 overexpression promotes the growth of NOK-SI cells.
- MAGEA4 inhibits G1 phase cell cycle arrest.
- MAGEA4 suppresses G418-induced apoptosis in NOK-SI cells.
- Apoptosis inhibition correlates with repression of BAX and CDKN1A.
Conclusions:
- MAGEA4 promotes cancer cell proliferation by interfering with cell cycle regulation.
- MAGEA4 exhibits anti-apoptotic functions, potentially through the p53 pathway.
- Understanding MAGEA4's role provides insights for cancer immunotherapy strategies targeting CTAs.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mesenchymal Stem Cells

